{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:51:17Z","timestamp":1793757077966,"version":"4.6.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173266 and 82573227"],"award-info":[{"award-number":["82173266 and 82573227"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82560599, 82372766"],"award-info":[{"award-number":["82560599, 82372766"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2024ZD0525700"],"award-info":[{"award-number":["2024ZD0525700"]}]},{"name":"Guangdong Basic and Applied Basic Research Foundation Project","award":["2024A1515140165"],"award-info":[{"award-number":["2024A1515140165"]}]},{"name":"Guangdong S&T Program","award":["2023B1111030006"],"award-info":[{"award-number":["2023B1111030006"]}]},{"name":"Guangzhou Key Laboratory of Organ Transplantation","award":["2025A03J4036"],"award-info":[{"award-number":["2025A03J4036"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025M782383"],"award-info":[{"award-number":["2025M782383"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2025YFC2424200 and 2023YFC2507003"],"award-info":[{"award-number":["2025YFC2424200 and 2023YFC2507003"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangdong Province Medical Science and Technology Research Fund","award":["A2022541"],"award-info":[{"award-number":["A2022541"]}]},{"name":"Guangzhou Science and Technology Program","award":["2025B03J0108"],"award-info":[{"award-number":["2025B03J0108"]}]},{"name":"Yixian Clinical Research Project 5010","award":["SYS-5010-202503"],"award-info":[{"award-number":["SYS-5010-202503"]}]},{"name":"Shenzhen Key Industry Research and Development Program","award":["ZDCY20250901102503004"],"award-info":[{"award-number":["ZDCY20250901102503004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13022-1","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T08:54:28Z","timestamp":1773046468000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Beyond valganciclovir: A meta-analysis of letermovir\u2019s safety and efficacy in cytomegalovirus prophylaxis after solid organ transplantation"],"prefix":"10.1186","volume":"26","author":[{"given":"Muhammad","family":"Usman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xutao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouhang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kewei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"issue":"9","key":"13022_CR1","doi-asserted-by":"publisher","first-page":"e13512","DOI":"10.1111\/ctr.13512","volume":"33","author":"RR Razonable","year":"2019","unstructured":"Razonable RR, Humar A. Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transpl. 2019;33(9):e13512.","journal-title":"Clin Transpl"},{"issue":"6","key":"13022_CR2","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/TP.0000000000002191","volume":"102","author":"CN Kotton","year":"2018","unstructured":"Kotton CN, Kumar D, Caliendo AM, Huprikar S, Chou S, Danziger-Isakov L, et al. The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation. Transplantation. 2018;102(6):900\u201331.","journal-title":"Transplantation"},{"issue":"12","key":"13022_CR3","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s41579-021-00582-z","volume":"19","author":"P Griffiths","year":"2021","unstructured":"Griffiths P, Reeves M. Pathogenesis of human cytomegalovirus in the immunocompromised host. Nat Rev Microbiol. 2021;19(12):759\u201373.","journal-title":"Nat Rev Microbiol"},{"issue":"14","key":"13022_CR4","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1001\/jama.2020.3138","volume":"323","author":"N Singh","year":"2020","unstructured":"Singh N, Winston DJ, Razonable RR, Lyon GM, Silveira FP, Wagener MM, et al. Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors: A Randomized Clinical Trial. JAMA. 2020;323(14):1378\u201387.","journal-title":"JAMA"},{"issue":"9","key":"13022_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.4254\/wjh.v2.i9.325","volume":"2","author":"SO Lee","year":"2010","unstructured":"Lee SO, Razonable RR. Current concepts on cytomegalovirus infection after liver transplantation. World J Hepatol. 2010;2(9):325\u201336.","journal-title":"World J Hepatol"},{"issue":"5","key":"13022_CR6","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/j.1600-6143.2010.03074.x","volume":"10","author":"A Humar","year":"2010","unstructured":"Humar A, Lebranchu Y, Vincenti F, Blumberg EA, Punch JD, Limaye AP, et al. The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients. Am J Transpl. 2010;10(5):1228\u201337.","journal-title":"Am J Transpl"},{"issue":"2","key":"13022_CR7","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1177\/1526924818765798","volume":"28","author":"X Liang","year":"2018","unstructured":"Liang X, Famure O, Li Y, Kim SJ. Incidence and Risk Factors for Leukopenia in Kidney Transplant Recipients Receiving Valganciclovir for Cytomegalovirus Prophylaxis. Prog Transpl. 2018;28(2):124\u201333.","journal-title":"Prog Transpl"},{"issue":"9","key":"13022_CR8","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1097\/01.ASN.0000079616.71891.F5","volume":"14","author":"GA Knoll","year":"2003","unstructured":"Knoll GA, MacDonald I, Khan A, Van Walraven C. Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation. J Am Soc Nephrol. 2003;14(9):2381\u20136.","journal-title":"J Am Soc Nephrol"},{"key":"13022_CR9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1182\/asheducation-2010.1.281","volume":"2010","author":"EP Smith","year":"2010","unstructured":"Smith EP. Hematologic disorders after solid organ transplantation. Hematol Am Soc Hematol Educ Program. 2010;2010:281\u20136.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"3","key":"13022_CR10","doi-asserted-by":"publisher","first-page":"e14279","DOI":"10.1111\/tid.14279","volume":"26","author":"S Martinez","year":"2024","unstructured":"Martinez S, Sindu D, Nailor MD, Cherrier L, Tokman S, Walia R, et al. Evaluating the efficacy and safety of letermovir compared to valganciclovir for the prevention of human cytomegalovirus disease in adult lung transplant recipients. Transpl Infect Dis. 2024;26(3):e14279.","journal-title":"Transpl Infect Dis"},{"issue":"5","key":"13022_CR11","doi-asserted-by":"publisher","first-page":"e14337","DOI":"10.1111\/tid.14337","volume":"26","author":"HL Kleiboeker","year":"2024","unstructured":"Kleiboeker HL, Wang J, Borkowski N, Miner B, Prom A, Paplaczyk K, et al. Use of letermovir for cytomegalovirus primary prophylaxis in lung transplant recipients. Transpl Infect Dis. 2024;26(5):e14337.","journal-title":"Transpl Infect Dis"},{"issue":"25","key":"13022_CR12","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","volume":"377","author":"FM Marty","year":"2017","unstructured":"Marty FM, Ljungman P, Chemaly RF, Maertens J, Dadwal SS, Duarte RF, et al. Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation. N Engl J Med. 2017;377(25):2433\u201344.","journal-title":"N Engl J Med"},{"issue":"1","key":"13022_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/jama.2023.9106","volume":"330","author":"AP Limaye","year":"2023","unstructured":"Limaye AP, Budde K, Humar A, Vincenti F, Kuypers DRJ, Carroll RP, et al. Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients: A Randomized Clinical Trial. JAMA. 2023;330(1):33\u201342.","journal-title":"JAMA"},{"issue":"5","key":"13022_CR14","doi-asserted-by":"publisher","first-page":"e70169","DOI":"10.1111\/ctr.70169","volume":"39","author":"HL Kleiboeker","year":"2025","unstructured":"Kleiboeker HL, Descourouez JL, Saddler CM, Al-Adra D, Rice JP, Jorgenson MR. De Novo Letermovir for Cytomegalovirus Prophylaxis in High-Risk Liver Transplant Recipients. Clin Transpl. 2025;39(5):e70169.","journal-title":"Clin Transpl"},{"key":"13022_CR15","doi-asserted-by":"crossref","unstructured":"Chow JKL, Vest AR, DeNofrio D, Snydman DR. Tolerability and clinical efficacy of letermovir for primary cytomegalovirus prophylaxis after heart transplantation. J Heart Lung Transplant. 2026;45(1):148-56.","DOI":"10.1016\/j.healun.2025.08.023"},{"issue":"4","key":"13022_CR16","doi-asserted-by":"publisher","first-page":"e13570","DOI":"10.1111\/tid.13570","volume":"23","author":"RJ Winstead","year":"2021","unstructured":"Winstead RJ, Kumar D, Brown A, Yakubu I, Song C, Thacker L, et al. Letermovir prophylaxis in solid organ transplant-Assessing CMV breakthrough and tacrolimus drug interaction. Transpl Infect Dis. 2021;23(4):e13570.","journal-title":"Transpl Infect Dis"},{"key":"13022_CR17","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"4","key":"13022_CR18","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/j.1600-6143.2004.00382.x","volume":"4","author":"C Paya","year":"2004","unstructured":"Paya C, Humar A, Dominguez E, Washburn K, Blumberg E, Alexander B, et al. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transpl. 2004;4(4):611\u201320.","journal-title":"Am J Transpl"},{"issue":"7","key":"13022_CR19","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1097\/TP.0000000000005374","volume":"109","author":"CN Kotton","year":"2025","unstructured":"Kotton CN, Kumar D, Manuel O, Chou S, Hayden RT, Danziger-Isakov L, et al. The Fourth International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation. Transplantation. 2025;109(7):1066\u2013110.","journal-title":"Transplantation"},{"issue":"9","key":"13022_CR20","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1111\/j.1600-6143.2007.01910.x","volume":"7","author":"A Asberg","year":"2007","unstructured":"Asberg A, Humar A, Rollag H, Jardine AG, Mouas H, Pescovitz MD, et al. Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients. Am J Transpl. 2007;7(9):2106\u201313.","journal-title":"Am J Transpl"},{"issue":"8","key":"13022_CR21","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1007\/s10157-024-02471-0","volume":"28","author":"H Ishida","year":"2024","unstructured":"Ishida H, Goto N, Imamura R, Sasaki H, Unagami K, Futamura K, et al. Letermovir safety and efficacy for cytomegalovirus prophylaxis in adult Japanese kidney transplant recipients: a multicenter, open-label, noncomparative Phase 3 study. Clin Exp Nephrol. 2024;28(8):822\u201331.","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"13022_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1001\/jama.2023.9100","volume":"330","author":"Z Raglow","year":"2023","unstructured":"Raglow Z, Kaul DR. A New Antiviral Option for Cytomegalovirus Prevention After Kidney Transplant. JAMA. 2023;330(1):27\u20139.","journal-title":"JAMA"},{"key":"13022_CR23","doi-asserted-by":"publisher","first-page":"100149","DOI":"10.1016\/j.jhlto.2024.100149","volume":"6","author":"AK Mezochow","year":"2024","unstructured":"Mezochow AK, He KD, Whitaker K, Blumberg E, Crespo MM, Courtwright A. Letermovir use for cytomegalovirus prophylaxis following lung transplantation: A single-center review. JHLT Open. 2024;6:100149.","journal-title":"JHLT Open"},{"issue":"5","key":"13022_CR24","doi-asserted-by":"publisher","first-page":"e15327","DOI":"10.1111\/ctr.15327","volume":"38","author":"G Saltiel","year":"2024","unstructured":"Saltiel G, Faure E, Assaf A, Chopin MC, Moreau F, Faure K, et al. Real-life use of letermovir prophylaxis for cytomegalovirus in heart transplant recipients. Clin Transpl. 2024;38(5):e15327.","journal-title":"Clin Transpl"},{"issue":"2","key":"13022_CR25","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s40121-022-00746-1","volume":"12","author":"CN Kotton","year":"2023","unstructured":"Kotton CN, Kamar N. New Insights on CMV Management in Solid Organ Transplant Patients: Prevention, Treatment, and Management of Resistant\/Refractory Disease. Infect Dis Ther. 2023;12(2):333\u201342.","journal-title":"Infect Dis Ther"},{"key":"13022_CR26","doi-asserted-by":"crossref","unstructured":"Hakimi Z, Aball\u00e9a S, Ferchichi S, Scharn M, Odeyemi IA, Toumi M, et al. Burden of cytomegalovirus disease in solid organ transplant recipients: a national matched cohort study in an inpatient setting. Transpl Infect Dis. 2017;19(5).","DOI":"10.1111\/tid.12732"},{"issue":"2","key":"13022_CR27","doi-asserted-by":"publisher","first-page":"e14227","DOI":"10.1111\/tid.14227","volume":"26","author":"S Belga","year":"2024","unstructured":"Belga S, Hernandez C, Kabbani D, Cervera C. Incidence of valganciclovir-related leukopenia and neutropenia in solid organ transplant recipients at high risk of cytomegalovirus disease. Transpl Infect Dis. 2024;26(2):e14227.","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"13022_CR28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.36469\/jheor.2025.125097","volume":"12","author":"Q Li","year":"2025","unstructured":"Li Q, Turzhitsky V, Moise P, Jin H, Brzozowski K, Kolobova I. Healthcare Resource Utilization Associated with Leukopenia and Neutropenia in Kidney Transplant Recipients Receiving Valganciclovir in the United States. J Health Econ Outcomes Res. 2025;12(1):22\u20139.","journal-title":"J Health Econ Outcomes Res"},{"issue":"2","key":"13022_CR29","doi-asserted-by":"publisher","first-page":"102671","DOI":"10.5500\/wjt.v15.i2.102671","volume":"15","author":"AP Beyer","year":"2025","unstructured":"Beyer AP, Moise PA, Wong M, Gao W, Xiang C, Shen P, et al. Clinical events and healthcare resource utilization associated with neutropenia and leukopenia among adult kidney transplant recipients receiving valganciclovir. World J Transpl. 2025;15(2):102671.","journal-title":"World J Transpl"},{"key":"13022_CR30","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.2147\/DDDT.S265644","volume":"18","author":"RR Razonable","year":"2024","unstructured":"Razonable RR. Current Perspectives on Letermovir and Maribavir for the Management of Cytomegalovirus Infection in Solid Organ Transplant Recipients. Drug Des Devel Ther. 2024;18:3987\u20134001.","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"13022_CR31","doi-asserted-by":"publisher","first-page":"106220","DOI":"10.1016\/j.jinf.2024.106220","volume":"89","author":"SM Hopff","year":"2024","unstructured":"Hopff SM, Wingen-Heimann SM, Classen AY, Blau IW, Bug G, Hebermehl C, et al. Real-world experience with letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation: A multi-centre observational study. J Infect. 2024;89(2):106220.","journal-title":"J Infect"},{"issue":"7","key":"13022_CR32","doi-asserted-by":"publisher","first-page":"ofae353","DOI":"10.1093\/ofid\/ofae353","volume":"11","author":"M Foca","year":"2024","unstructured":"Foca M, Demirhan S, Munoz FM, Valencia Deray KG, Bocchini CE, Sharma TS, et al. Multicenter Analysis of Valganciclovir Prophylaxis in Pediatric Solid Organ Transplant Recipients. Open Forum Infect Dis. 2024;11(7):ofae353.","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"13022_CR33","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.jinf.2014.07.001","volume":"69","author":"C Mart\u00edn-Gandul","year":"2014","unstructured":"Mart\u00edn-Gandul C, P\u00e9rez-Romero P, Gonz\u00e1lez-Roncero FM, Berdaguer S, G\u00f3mez MA, Lage E, et al. Clinical impact of neutropenia related with the preemptive therapy of CMV infection in solid organ transplant recipients. J Infect. 2014;69(5):500\u20136.","journal-title":"J Infect"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13022-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13022-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13022-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T10:33:44Z","timestamp":1775212424000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13022-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13022"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13022-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"9 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This meta-analysis was conducted using data extracted from published studies. No new human participants were involved; therefore, ethics approval and consent to participate are not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"708"}}